Patient portrayal of a woman sitting at a kitchen counter looking at a laptop computer
Patient portrayal of a woman sitting at a kitchen counter looking at a laptop computer

Qfitlia™ Patient Support

Whether you're starting Qfitlia to treat Hemophilia A or B for the first time or are looking for ongoing support, we've got resources for you.

Start your Qfitlia journey with HemAssist

Once you’ve been prescribed Qfitlia, you can enroll in HemAssist to get the support you need to start and stay with treatment. We offer financial assistance, including copay assistance, for eligible patients, help you navigate insurance, and provide supplemental training on how to inject, and more.

After you enroll, your HemAssist team will call you within 24 hours to welcome you to the program and explain what to expect. Save 1-833-723-5463 to your contacts. Learn how to enroll

Large Qfitlia Logo

OUR SUPPORT

Decorative wallet icon

Affording Qfitlia

No matter your situation, we are committed to helping you access and afford Qfitlia. Your team will verify your insurance coverage and determine what financial assistance programs you may be eligible for.

Decorative 1-2-3 steps icon

Starting treatment

Your team can help you get started with Qfitlia right away. We'll provide supplemental training on how to inject, answer questions about antithrombin (AT) testing, and support your bleed management plan.

Decorative conversation bubble icon

Ongoing support

Our team provides support and education throughout your treatment journey. This includes helping you understand dosing changes from your doctor, navigating new insurance, and more.

Financial assistance

Regardless of your insurance status, our team is here to help. If you need help paying for medication, we can help determine if you may be eligible for financial assistance.

Copay Assistance Program*

If you’re having trouble paying for Qfitlia, HemAssist’s Copay Assistance Program may be able to help. Get Qfitlia for as little as $0.

HemAssist copay card image

QuickStart Program†

Patients prescribed Qfitlia for the first time can receive up to 6 months of product while their insurance coverage is pending.

Patient portrayal of a man smiling and looking at a phone sitting on a couch

Patient Assistance Program†

HemAssist’s Patient Assistance Program may be available to help eligible Qfitlia patients who are uninsured, underinsured, or experiencing a temporary loss in insurance coverage.

Patient portrayal of a woman sitting on the floor with her laptop

* Not valid if the patient is utilizing a state or federally funded health insurance program such as Medicare (including Medicare Part D), Medicaid, Medigap, VA, DoD, TRICARE®, state pharmaceutical assistance program, etc. to pay in part or in full for their Qfitlia prescription. Not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Copay Program at any time without notice. Savings by patients may vary depending on their out-of-pocket costs. The program is intended to help patients afford their Qfitlia prescription. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms.

† Claims for free products dispensed through the QuickStart or Patient Assistance Programs shall not be submitted to any third-party payer, public or private (e.g. private insurance, Medicaid, Medicare, VA, DoD, TRICARE®, or similar federal or state programs) for reimbursement. All Programs not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Programs at any time without notice. Program details provided upon registration.

Have questions?

Our team is here to assist you.

Call 1-833-723-5463 Monday - Friday 8 AM to 7 PM ET.

Meet your team
Image of four HemAssist team members sitting around a conference table

Getting started on Qfitlia

Once you've enrolled, your Case Manager and Clinical Educator will call to welcome you to HemAssist within 24 hours. Your Case Manager will conduct an insurance investigation to understand your coverage. Your Clinical Educator will review everything you need to know about getting started with Qfitlia, including antithrombin (AT) testing and reviewing your bleed management plan. During the first few months on treatment, your Clinical Educator can help you with supplemental injection training, understanding the dosing adjustment process, and more.

Call 1-833-723-4563 Monday - Friday 8 AM to 7 PM to speak with you Case Manager or Clinical Educator. You can also get started with the resources below.

Patient portrayal of a man and woman  sitting on a sofa looking at a laptop computer

RESOURCES FOR STARTING QFITLIA

Decorative download icon

Qfitlia starter guide

Decorative injection video icon

Injection training videos

Decorative download icon

Bleed management guide

Support along the way

Starting a new treatment may come with a lot to learn. That’s why, from the moment you enroll, you have a dedicated HemAssist team with support on your side. From digital resources to personalized check-ins, HemAssist is here to help you get started with confidence. Learn more about your team below and enroll to get started with support.

MEET YOUR TEAM

Portrayal of a professional woman sitting at desk wearing a headset

Clinical Educator (CE)

Provides guidance throughout your Qfitlia journey. Answers questions about injecting, antithrombin (AT) testing, dosing changes prescribed by your doctor, building an injection routine, and more.

Your Clinical Educator will not provide personal medical advice. For all questions about your individual health needs, consult with your treating physician.

Portrayal of a man sitting at desk wearing a headset

Case Manager

Case Managers provide you with personalized insurance investigations and answer questions about financial assistance options for eligible patients. They can help coordinate treatment shipments and assist with reimbursements.

Portrayal of a man sitting speaking on a mobile phone

Community Relations and Education Manager (CoRe)

CoRes are dedicated to providing education and empowering those within the hemophilia community through one-to-one communication, as well as through community events and conferences.

REASONS TO REACH OUT

Your Clinical Educator and Case Manager are available to assist you at any point along your Qfitlia journey.

Your doctor may adjust your dose if your antithrombin (AT) levels are outside the normal range. Your Clinical Educator can help you understand your dosing and what it means for you. Call 1-833-723-5463 Monday - Friday 8 AM to 7 PM ET.

Your Clinical Educator can provide supplemental injection training support along with helpful tips about building a treatment routine. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

When you change or start new insurance, you may have questions about affording Qfitlia. Contact your Case Manager for help navigating the process. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

These are important milestones not only in adulthood, but also in treatment responsibility. Your team can help you navigate life changes such as going to college, starting a new job, or choosing insurance for the first time. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

Starting and staying with a new treatment takes dedication. Your Clinical Educator can help with tips for injection day, building your treatment routine, and help maintaining motivation when you need it. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.

Resources from the community

National Bleeding Disorders Foundation logo

National Bleeding Disorders Foundation

Hemophilia federation of America logo

Hemophilia federation of America

World Federation of Hemophilia logo

World Federation of Hemophilia

National organization for rare disorders logo

National Organization for Rare Disorders

This listing is provided as a resource only and does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources on this topic may be available and should be investigated. Sanofi does not review or control the content of non-Sanofi websites.

Ready to enroll in HemAssist?

Get started with support in just a few steps. You can enroll online or download an enrollment form and bring it to your doctor’s office.

Learn how to enroll
Patient portrayal of a man sitting at a laptop and talking on a mobile phone.

IMPORTANT SAFETY INFORMATION AND INDICATION
INDICATION
IMPORTANT SAFETY INFORMATION
INDICATION

Qfitlia™ (fitusiran) is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years and older with hemophilia A or B with or without Factor VIII or IX inhibitors.

It is not known if Qfitlia is safe and effective in children younger than 12 years of age.

IMPORTANT SAFETY INFORMATION

Qfitlia can cause SERIOUS SIDE EFFECTS, including:

  • Abnormal blood clotting (thrombotic events): Serious blood clots have occurred in people treated with Qfitlia. Qfitlia can cause blood clots to form in the blood vessels in your arms, legs, lungs, heart, brain, eyes, or head. Your risk of blood clots is greater if your antithrombin (AT) blood level is persistently less than 15% or if you have certain other conditions. Your healthcare provider (HCP) will check your AT blood levels before and during treatment with Qfitlia

  • Gallbladder disease: Qfitlia can cause gallstones and inflammation of your gallbladder, which might require surgery to remove your gallbladder. Tell your HCP right away if you develop stomach pain, indigestion, nausea, or vomiting. Your HCP may temporarily or permanently stop Qfitlia if you develop any of these symptoms


What is the most important information I should know about Qfitlia?


Qfitlia helps your blood form clots. Do not stop using Qfitlia without talking to your HCP. If you miss doses or stop using Qfitlia, you may no longer be protected against bleeding.


Use of a clotting factor concentrate (CFC) or bypassing agent (BPA) to help protect against bleeding must be stopped within 7 days after your first dose of Qfitlia.


Your HCP may prescribe on-demand CFC or BPA if you bleed during treatment with Qfitlia. Carefully follow your HCP’s instructions regarding when to use on-demand treatment with CFC or BPA, including the prescribed dose and timing of the CFC or BPA.


Get medical help right away if you get any of these signs or symptoms of blood clots during or after treatment with Qfitlia:

  • Swelling, pain, or redness in arms or legs
  • Coughing up blood
  • Shortness of breath
  • Severe chest pain or tightness of the chest
  • Fast heart rate
  • Feeling faint or passing out
  • Severe or persistent headache
  • Difficulty speaking or understanding language
  • Feeling confused
  • Numbness or weakness in your face, arms, or legs
  • Sudden loss or changes in your vision, eye pain, or swelling


What are the possible side effects of Qfitlia?

  • Qfitlia can cause other serious side effects, including an increase in your blood liver enzymes. Your HCP will do blood tests to check your liver function before and during treatment with Qfitlia

  • The most common side effects of Qfitlia include viral infection, common cold symptoms, and bacterial infection

These are not all the possible side effects of Qfitlia.


What should I tell my HCP before using Qfitlia?

  • Tell your HCP about all of your medical conditions, including if you have liver problems, a history of gallbladder disease, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed

  • Females who are able to become pregnant: Hormonal birth control may increase your risk of blood clots if used during treatment with Qfitlia. Talk to your HCP about effective forms of non-hormonal birth control you can use before starting and during treatment with Qfitlia

  • Tell your HCP about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements

© 2025 Sanofi. All rights reserved. Qfitlia, HemAssist and Sanofi are trademarks of Sanofi or an affiliate. All other trademarks are the property of their respective owners. MAT-US-2505192-v1.0-08/2025